Press Releases
3 hours ago
Akkarco LLC Recalls Product Due to Possible Health Risk
Gov't Institution
U.S. Food and Drug Administration
Owner: American Government
an hour ago
Akkarco LLC Recalls Product Due to Possible Health Risk
Gov't Institution
U.S. Food and Drug Administration
Owner: American Government
3 hours ago
Kootenai Accountable Care Partners with Ceresti Health on Dementia Care
Neutral
EIN Presswire
3 hours ago
Ballad Health welcomes Mike Anderes as managing director of Ballad Ventures
Indeterminate
GlobeNewswire, Inc.
4 hours ago
Banner Health taps finance leader for strategy and growth role
Indeterminate
GlobeNewswire, Inc.
2 hours ago
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon health
Indeterminate
GlobeNewswire, Inc.
5 hours ago
Cabot Corporation Reports First Quarter Fiscal Year 2026 Results
Indeterminate
GlobeNewswire, Inc.
5 hours ago
BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026
Indeterminate
GlobeNewswire, Inc.
5 hours ago
Tactile Medical to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 17, 2026
Indeterminate
GlobeNewswire, Inc.
5 hours ago
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conference
Indeterminate
GlobeNewswire, Inc.
5 hours ago
BioStem Technologies Highlights Alignment with FDA’s Openness to Bayesian Statistical Approaches in Clinical Research
Indeterminate
GlobeNewswire, Inc.
5 hours ago
Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
Indeterminate
GlobeNewswire, Inc.
7 hours ago
Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions
Gov't Institution
U.S. Food and Drug Administration
Owner: American Government
7 hours ago
New Source Technology Announces Participation in Laser World of Photonics China
Neutral
EIN Presswire
7 hours ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ultragenyx Pharmaceutical Inc. – RARE
Indeterminate
GlobeNewswire, Inc.